Why the study?
Acute or intense exercise can trigger metabolic imbalances, muscle injuries, or unmask hidden disorders, prompting the need to explore the causes of deep venous thrombosis in an elite athlete.
What is the molecular basis of a deep vein thrombosis event in an elite basketball athlete?
What is the molecular basis of a deep vein thrombosis event in an elite basketball athlete?
An integrated diagnostic approach in an elite athlete with DVT revealed an underlying CALR mutation causing Essential Thrombocythemia and acquired von Willebrand disease.
Answers are grounded in this paper and cite their sources.
Integrated diagnostics may aid thrombosis workup in athletes; leaves open generalizability pending larger studies.
Acute or intense exercise can result in metabolic imbalances, muscle injuries, or reveal hidden disorders. Laboratory medicine in sports is playing an increasingly crucial role in monitoring athletes’ health conditions. In this study, we designed an integrated approach to explore the causes of a deep venous thrombosis event in an elite basketball player. Since the complete blood count revealed a marked platelet count (838 × 103 µL), and thrombophilia screening tests did not reveal any significant alteration, we evaluated the thrombin generation, which highlights a state of hypercoagulability. First-level haemostasis exams showed only a slight prolongation of the activated Partial Thromboplastin Time (aPTT). Thus, screening tests for von Willebrand Disease showed a reduction in vWF parameters. Therefore, we directed our hypothesis towards a diagnosis of acquired von Willebrand disease secondary to Essential Thrombocythemia (ET). To confirm this hypothesis and highlight the molecular mechanism underlying the observed phenotype, molecular tests were performed to evaluate the presence of the most common mutations associated with ET, revealing a 52-bp deletion in the coding region of CALR exon 9. This case report highlights the importance of an integrated approach to monitoring the athletes’ health status to personalise training and treatments, thus avoiding the appearance of diseases and injuries that, if underestimated, can undermine the athlete’s life.
No takes yet. Share an insight, caveat, or question.
Mennitti et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: